Abstract: An arch support orthotic device comprises an upper surface facing a wearer's foot, and a lower surface facing a footwear, wherein the upper surface is formed of a deformable semi-rigid material responding flexibly to a weight of the wearer, and wherein the lower surface comprises an arch support section facing an inner sole surface of the footwear including a plurality of support structures that performs an arch supporting function, controls a deformability of the orthotic device so as to reduce loss of the arch supporting function when worn by the wearer, and prevents substantial deformation against the inner sole surface of the footwear.

Abstract: An arch support orthotic device is insertable into an item of footwear which comprises an upper surface and a lower surface, the upper surface of which is contoured to conform generally to the shape of the arch of a wearer's foot and is formed of a deformable semi-rigid material responding flexibly to the weight of the wearer and the lower surface of which faces the shoe inner sole surface of the item of footwear when inserted into said item, said lower surface comprising a plurality of ribs and crenellations, wherein said ribs and crenellations function during use to control the deformability of the device so as to reduce loss of the arch supporting function when worn by the wearer while preventing essentially complete deformation against the shoe inner sole surface of the wearer's footwear.

Abstract: A method of advertising utilizing a break, interval or hiatus in a telephone system connection with a caller or recipient, wherein during said break, an advertising message is delivered to the caller or recipient of a call.

Abstract: The present invention centers around the treatment of peripheral neuropathy by administering to a symptomatic patient, especially one suffering pain and/or burning symptoms and especially in the legs or feet, and soles of the feet, a combination of two medications, a substituted phenothiazine, and a tricyclic antidepressant. The substituted phenothiazine potentiates the activity of, or acts synergistically with the tricyclic antidepressant, to provide relief that is otherwise not obtainable with one medication alone at reasonable dosage levels. The particular antidepressant may be imipramine (or analog thereof) and may be selected from the group consisting of the following well-known antidepressants: desipramine, imipramine, imipramine N-oxide, tripripramine, clomipramine, doxepin, amitriptyline, nortriptyline, protriptyline, and their pharmaceutically acceptable free forms, and acid addition salts and esters thereof. The second compound of the regimen is a substituted phenothiazine.